Abstract:Linear aromatic N-tricyclic compounds with promising antiviral activity and minimal cytotoxicity were prepared and analyzed in the last years. Specifically, the pyrido[2,3-g]quinoxalinone nucleus was found endowed with high potency against several pathogenic RNA viruses as etiological agents of important veterinary and human pathologies. Following our research program on new antiviral agents we have designed, synthesized and assayed new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. Lead compounds 1-4 were further modified to enhance their antiviral activity and reduce their cytotoxicity. Thus, different substituents were introduced on N atom at position 1 or the O atom at position 2 of the leads; contextually, several groups were inserted on the nitrogen atom at position 7 of diaminoquinoline intermediates. Title compounds were tested in cell-based assays for cytotoxicity and antiviral activity against RNA virus families containing single-stranded (either positive-sense (ssRNA+) or negative-sense (ssRNA-)), and double-stranded genomes (dsRNA), and against two representatives of DNA virus families. Some derivatives emerged as potential leads for further development as antiviral agents against some viruses of public health significance, such as RSV, Reo, BVDV and HCV. Particularly, compounds 4, 11b, 11c, 13c, 15a, 18 and 21 resulted active against BVDV at concentrations ranging from 1.3 to 5 μM. Compound 21 was also evaluated for its activity on the BVDV RdRp. Compound 4 was also tested as potential anti-HCV compound in a subgenomic replication assay. Molecular simulation results provided a molecular rationale for the anti-BVDV activity of these compounds.

Design, Synthesis, and Antiviral Properties of 2-Aryl-1h-benzimidazole-4-carboxamide Derivatives

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Design, Synthesis and Biological Activity of Some Novel Benzimidazole Derivatives Against Coxsackie Virus B3

Synthesis and Antiviral Activity Against Coxsackie Virus B3 of Some Novel Benzimidazole Derivatives.

Synthesis of Novel Benzimidazole Derivatives and Their Antivirus Activity against Coxsackie Virus B3

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Design, synthesis, and antiviral activities evaluation of novel quinazoline derivatives containing sulfonamide moiety

Inhibitory Properties of 2-Substituent-1h-benzimidazole-4-carboxamide Derivatives Against Enteroviruses

Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives Bearing A Heterocyclic Ring at 4/5 Position

Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors

Design, Synthesis and Inhibitory Properties Against Coxsackie B3/B6 of Some Novel Triazole Derivatives

Novel flavonol derivatives containing benzoxazole as potential antiviral agents: design, synthesis, and biological evaluation

Synthesis, Characterization, and Biological Evaluation of Some Novel Quinoxaline Derivatives as Antiviral Agents

Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives

Design, Synthesis and in Vitro Anti-Influenza A Virus Evaluation of Novel Quinazoline Derivatives Containing S-acetamide and NH-acetamide Moieties at C-4

Synthesis and Antiviral Activity of a Series of Novel Quinoline Derivatives As Anti-Rsv or Anti-Iav Agents

Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives

Synthesis and Antiviral Evaluation of Novel N-6 Substituted Adenosine Analogues

Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors

Design, Synthesis, and Anti-Influenza A Virus Activity Evaluation of Novel Indole Containing Derivatives of Triazole

Design and Synthesis of a New Class of Pyridine-Based N-Sulfonamides Exhibiting Antiviral, Antimicrobial, and Enzyme Inhibition Characteristics